Burning Rock Biotech (BNR) Change in Accured Expenses (2019 - 2025)

Burning Rock Biotech's Change in Accured Expenses history runs 7 years deep, the most recent figure standing at $11.4 million for Q4 2025.

• In Q4 2025, Change in Accured Expenses fell 8.5% year-over-year to $11.4 million; the TTM figure through Dec 2025 stood at $11.4 million (down 8.5% YoY), while the FY2025 annual figure was $11.6 million, down 5.7% from the prior year.
• Change in Accured Expenses was $11.4 million for Q4 2025 at Burning Rock Biotech, up from $10.8 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $24.4 million in Q4 2022 to a low of $9.2 million in Q1 2021.
• Historically, Change in Accured Expenses has averaged $14.5 million across 5 years, with a median of $13.0 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Change in Accured Expenses soared 77.94% in 2022, then tumbled 44.98% in 2024.
• A 5-year view of Change in Accured Expenses shows it stood at $20.0 million in 2021, then advanced by 22.19% to $24.4 million in 2022, then slumped by 40.37% to $14.6 million in 2023, then slipped by 14.51% to $12.5 million in 2024, then declined by 8.5% to $11.4 million in 2025.
• The last three Change in Accured Expenses figures came in at $11.4 million (Q4 2025), $10.8 million (Q3 2025), and $10.5 million (Q2 2025), per Business Quant data.